Yongchang Gao1, Jianjing Liu2, Xiaolong Qian3, Xianghui He1. 1. Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China. 2. Department of Nuclear Medicine and Molecular Imaging, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China. 3. Department of Breast Cancer Pathology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Abstract
BACKGROUND: Brain metastasis from breast cancer (BC) is an important cause of BC-related death. The present study aimed to identify markers of brain metastasis from BC. METHODS: Datasets were downloaded from the public databases Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA). Weighted gene co-expression network analysis (WGCNA) was performed to identify metastasis-associated genes (MAGs). Least absolute shrinkage and selection operator (LASSO) Cox proportional hazards regression models were constructed for screening key MAGs. Survival analysis and receiver operating characteristic (ROC) curves were used for evaluating the prognostic value. The factors associated with tumor metastasis were integrated to create a nomogram of TCGA data using R software. Gene Set Enrichment Analyses (GSEA) was performed for detecting the potential mechanisms of identified MAGs. Immunohistochemistry (IHC) was used to verify the expression of the key genes in clinical samples. RESULTS: The genes in 2 modules were identified to be significantly associated with metastasis through WGCNA. LASSO Cox proportional hazards regression models were constructed successfully. Subsequently, a clinical prediction model was constructed, and a nomogram was mapped, which had better sensitivity and specificity for BC metastasis. Two key genes, discs large homolog 3 (DLG3) and growth factor independence 1 (GFI1), were highly expressed in clinical samples, and the expression of these 2 genes was associated with patients' survival time. CONCLUSIONS: We successfully constructed a clinical prediction model for brain metastasis from BC, and identified that the expression of DLG3 and GFI1 were strongly associated with brain metastasis from BC. 2021 Gland Surgery. All rights reserved.
BACKGROUND: Brain metastasis from breast cancer (BC) is an important cause of BC-related death. The present study aimed to identify markers of brain metastasis from BC. METHODS: Datasets were downloaded from the public databases Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA). Weighted gene co-expression network analysis (WGCNA) was performed to identify metastasis-associated genes (MAGs). Least absolute shrinkage and selection operator (LASSO) Cox proportional hazards regression models were constructed for screening key MAGs. Survival analysis and receiver operating characteristic (ROC) curves were used for evaluating the prognostic value. The factors associated with tumor metastasis were integrated to create a nomogram of TCGA data using R software. Gene Set Enrichment Analyses (GSEA) was performed for detecting the potential mechanisms of identified MAGs. Immunohistochemistry (IHC) was used to verify the expression of the key genes in clinical samples. RESULTS: The genes in 2 modules were identified to be significantly associated with metastasis through WGCNA. LASSO Cox proportional hazards regression models were constructed successfully. Subsequently, a clinical prediction model was constructed, and a nomogram was mapped, which had better sensitivity and specificity for BC metastasis. Two key genes, discs large homolog 3 (DLG3) and growth factor independence 1 (GFI1), were highly expressed in clinical samples, and the expression of these 2 genes was associated with patients' survival time. CONCLUSIONS: We successfully constructed a clinical prediction model for brain metastasis from BC, and identified that the expression of DLG3 and GFI1 were strongly associated with brain metastasis from BC. 2021 Gland Surgery. All rights reserved.
Entities:
Keywords:
Brain metastasis from breast cancer (BMBC); discs large homolog 3 (DLG3); growth factor independence 1 (GFI1); least absolute shrinkage and selection operator (LASSO); nomogram
Authors: F Heitz; J Rochon; P Harter; H-J Lueck; A Fisseler-Eckhoff; J Barinoff; A Traut; F Lorenz-Salehi; A du Bois Journal: Ann Oncol Date: 2010-11-08 Impact factor: 32.976
Authors: N Hanada; K Makino; H Koga; T Morisaki; H Kuwahara; N Masuko; Y Tabira; T Hiraoka; N Kitamura; A Kikuchi; H Saya Journal: Int J Cancer Date: 2000-05-15 Impact factor: 7.396
Authors: Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov Journal: Proc Natl Acad Sci U S A Date: 2005-09-30 Impact factor: 11.205
Authors: Carey K Anders; Allison M Deal; C Ryan Miller; Carmen Khorram; Hong Meng; Emily Burrows; Chad Livasy; Karen Fritchie; Matthew G Ewend; Charles M Perou; Lisa A Carey Journal: Cancer Date: 2010-11-29 Impact factor: 6.860
Authors: Dana A M Mustafa; Rute M S M Pedrosa; Marcel Smid; Marcel van der Weiden; Vanja de Weerd; Alex L Nigg; Cor Berrevoets; Lona Zeneyedpour; Neibla Priego; Manuel Valiente; Theo M Luider; Reno Debets; John W M Martens; John A Foekens; Anieta M Sieuwerts; Johan M Kros Journal: Acta Neuropathol Date: 2018-01-19 Impact factor: 17.088